Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02751541 · ClinicalTrials.gov registry record · NA
Human Phototoxicity Test
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02751541: Completed NA study, sponsored by Bayer.
NCT02751541 is a NA study that has completed, run by Bayer. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02751541, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
To determine the phototoxic potential of a topically applied article in human subjects.
Interventions
- OTHER Untreated Skin
- DRUG Sunscreen Sport Spray (BAY987519)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-05-02 |
| Est. Completion | 2016-05-06 |
| Phase | NA |
What the finished NCT02751541 record still lists
NCT02751541 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Untreated Skin is the first listed.
NCT02751541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02751541 about?
NCT02751541 is a clinical study titled "Human Phototoxicity Test". To determine the phototoxic potential of a topically applied article in human subjects.
What is the current status of trial NCT02751541?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-05-02. Estimated completion is 2016-05-06.
What interventions are being tested in trial NCT02751541?
The interventions under investigation include: Untreated Skin (OTHER), Sunscreen Sport Spray (BAY987519) (DRUG).
Who is sponsoring clinical trial NCT02751541?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02751541's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI